Valuation: Qinghai Biotech Pharmaceutical Group Limited

Market Cap 15Cr 1.93Cr 1.75Cr 1.62Cr 1.46Cr 2.75Cr 181.84Cr 2.85Cr 19Cr 7.7Cr 97Cr 7.24Cr 7.08Cr 308.33Cr P/E 2024
-2.61x
P/E 2025 -7.56x
Enterprise Value 5.52Cr 70.31L 63.72L 58.93L 53.17L 1Cr 66Cr 1.04Cr 7.08Cr 2.81Cr 35Cr 2.64Cr 2.58Cr 112.42Cr EV / Sales 2024
-0.1x
EV / Sales 2025 1.85x
Free-Float
43.07%
Yield 2024 *
-
Yield 2025 -
1 month-7.89%
3 months-33.94%
6 months-70.80%
Current year-58.29%
1 week 1.46
Extreme 1.46000000
1.46
1 month 0.33
Extreme 0.33
1.58
Current year 0.33
Extreme 0.33
10.95
1 year 0.33
Extreme 0.33
10.95
3 years 0.33
Extreme 0.33
10.95
5 years 0.33
Extreme 0.33
10.95
10 years 0.33
Extreme 0.33
25.5
Manager TitleAgeSince
Chief Executive Officer 45 26/02/2019
Comptroller/Controller/Auditor 50 01/04/2016
Director TitleAgeSince
Chairman 45 02/12/2016
Director/Board Member 61 11/01/2017
Director/Board Member 62 05/03/2018
Date Insider Type Main position Quantity % Market Cap. Importance
22/07/20 Other

Director

60,00,000 0.1190%
22/07/20 Other

Chief Executive Officer

4,00,00,000 0.7933%
22/07/20 Other

Director

60,00,000 0.1190%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-66.44%-35.11% 1.93Cr
+1.18%-1.28%-16.05%+13.29% 19TCr
+1.85%+1.04%+6.99%+42.70% 12TCr
-0.88%-4.98%-17.08%+9.86% 12TCr
+1.36%-5.91%-43.00%+3.16% 9.14TCr
+2.96%+7.64%-1.76%+80.54% 6.67TCr
+1.08%+2.90%+12.95%-7.56% 5.88TCr
+0.89%+4.17%+0.39%+62.87% 5.5TCr
-0.68%+6.83%-1.64%+55.26% 4.99TCr
-1.28%-0.43% - - 3.51TCr
Average +0.37%-1.74%-13.96%+25.00% 8TCr
Weighted average by Cap. +0.45%-3.32%-9.99%+27.13%

Financials

2024 2025
Net sales 19Cr 2.36Cr 2.14Cr 1.98Cr 1.79Cr 3.37Cr 222.77Cr 3.49Cr 24Cr 9.43Cr 119Cr 8.87Cr 8.68Cr 377.73Cr 14Cr 1.77Cr 1.61Cr 1.49Cr 1.34Cr 2.53Cr 167.19Cr 2.62Cr 18Cr 7.08Cr 89Cr 6.65Cr 6.51Cr 283.49Cr
Net income -4.64Cr -59.09L -53.54L -49.52L -44.68L -84.21L -56Cr -87.17L -5.95Cr -2.36Cr -30Cr -2.22Cr -2.17Cr -94Cr -4.67Cr -59.5L -53.92L -49.87L -44.99L -84.79L -56Cr -87.78L -5.99Cr -2.38Cr -30Cr -2.23Cr -2.19Cr -95Cr
Net Debt -14Cr -1.77Cr -1.61Cr -1.48Cr -1.34Cr -2.52Cr -167.01Cr -2.61Cr -18Cr -7.07Cr -89Cr -6.65Cr -6.51Cr -283.18Cr -9.61Cr -1.23Cr -1.11Cr -1.03Cr -92.67L -1.75Cr -115.54Cr -1.81Cr -12Cr -4.89Cr -62Cr -4.6Cr -4.5Cr -195.92Cr
Projected Income Statement - Annual - Qinghai Biotech Pharmaceutical Group Limited
Logo Qinghai Biotech Pharmaceutical Group Limited
Kaisa Health Group Holdings Ltd, formerly Mega Medical Technology Ltd, is an investment holding company principally engaged in the manufacturing and sale of dental prosthetics and implant instruments. The Company operates its business through two segments. The Dental Business segment is mainly engaged in the manufacturing of and trading in dental products. The Health Care Business segment mainly engages in the provision of services for sport rehabilitation, including postoperative rehabilitation, sports injury rehabilitation, chronic pain, scoliosis, deformity correction, and other rehabilitation services, as well as health leisure business.
Employees
1,340
Date Price Change Volume
13/26/13 HK$1.460 0.00% 0
12/26/12 HK$1.460 0.00% 0
11/26/11 HK$1.460 0.00% 0
10/26/10 HK$1.460 0.00% 0
09/26/09 HK$1.460 0.00% 0